Education
About Us
Working with TipRanks
Follow Us
Grant Warren Hladun Insider Profile
4 Followers
Grant Warren Hladun, Director at Pharmacorp Rx Inc., holds 881.01K shares in Pharmacorp Rx Inc. (Ticker: TSE:PCRX). Most recently, Grant Warren Hladun Bought 131,010 shares of Pharmacorp Rx Inc. on Nov 14, 2025 for an estimated value of C$55.02K.
Grant Warren Hladun has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Grant Warren Hladun's holdings
Insider Roles
Director
Roles that Grant Warren Hladun holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Grant Warren Hladun
Grant Warren Hladun's Trading History
List of latest transactions for each holding click on a transaction to see Grant Warren Hladun's performance on stock
You May Also Like
Grant Warren Hladun insider profile FAQ
What is the percentage of profitable transactions made by Grant Warren Hladun?
The percentage of profitable transactions made by Grant Warren Hladun is ―.
What is the average return per transaction made by Grant Warren Hladun?
The average return per transaction made by Grant Warren Hladun is ―.
What stocks does Grant Warren Hladun hold?
Grant Warren Hladun holds: TSE:PCRX stocks.
What was Grant Warren Hladun’s latest transaction?
Grant Warren Hladun latest transaction was an Informative Buy of C$55.02K.
What was Grant Warren Hladun's most profitable transaction?
Grant Warren Hladun’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Grant Warren Hladun's role in Pharmacorp Rx Inc.?
Grant Warren Hladun's role in Pharmacorp Rx Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.